Please ensure Javascript is enabled for purposes of website accessibility

Big Companies Are Buying Into Biofuels

By Shamus Funk - Feb 16, 2014 at 2:52PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Big oil and chemical companies have financial resources and established infrastructure that is, at this point, unavailable to smaller biofuel companies. In the world of biofuels, maybe size does matter.

A handful of smaller companies like Solazyme (TVIA), Amyris (AMRS -3.53%), and Renewable Energy Group are often credited as being the future of biofuels, while many experts in the biofuel industry argue that a monumental investment would be necessary for biofuels to take off in the short term. While leaders of these smaller companies in the biofuel industry are unquestionably committed to the success of their businesses, the scale of investment necessary for biofuels to see widespread implementation is likely beyond the means of these smaller companies.

Larger companies from a variety of backgrounds, including ExxonMobil (XOM 2.36%), DuPont (DD), and BP (BP 2.01%), are seeing the potential in biofuels and are investing in a range of different advanced biofuel technologies. The resources available to these companies with market capitalizations that in some cases are over 1,000 times greater than smaller biofuel companies may make the companies' ventures into the biofuel industry that much more likely to succeed.

With size comes money
After spending over $100 million on the development of algae-based biofuels, ExxonMobil is refocusing its efforts on developing new, more productive strains of algae with the help of Synthetic Genomics.

The collaborative effort, which may result in ExxonMobil investing more than the massive $600 million originally expected for the development of algae-based fuels, is just one example of why the next great advances in biofuels may not originate from the younger start-up companies in the industry. The ability to wager and lose $100 million on higher-risk ventures like algae-based fuels would spell the end for a newer company, but can be easily written off by the world's largest oil company.

DuPont's research into cellulosic ethanol and BP's investments in biobutanol both further increase the likelihood of big developments in bio-based fuels arising from the ranks of established larger companies. Through the combined expertise of recently acquired subsidiaries Danisco and Genencor and itsown strong history of industrial bioscience, DuPont is a major producer of enzymes for traditional corn-based ethanol production and has set the necessary groundwork for large-scale production of cellulosic ethanol.

After the success of a demonstration-scale facility in Tennessee, DuPont is now nearing completion of a commercial-scale cellulosic ethanol production facility in Iowa. By the end of the year, the facility should be operational with expectations to produce 30 million gallons of fuel ethanol from corn stover feedstock.

DuPont's interest in advanced biofuels spreads beyond just cellulosic ethanol into less traditional bio-based fuels like propanediol and biobutanol. The company's Butamax endeavor into biobutanol production is in collaboration with BP, with plans to use the fuel in place of ethanol for gasoline blending.

The major advantage of biobutanol over ethanol is its higher blending percentage given current regulations. It is not clear how detrimental the proposed changes to the Renewable Fuel Standard (RFS) would be to biobutanol, but it remains an intriguing opportunity given the ability to produce the fuel at already existing ethanol production facilities.

Retrofitting existing ethanol facilities and providing the complete set of resources to transition at least in part to biobutanol production and subsequent commercialization allows BP and DuPont to invest in advanced biofuels without the complete expense of building entirely new facilities. The required investments into research and development for the venture are still substantial, but BP's established infrastructure and the combined technology from both companies increase the likelihood for commercial success of the joint venture.

The takeaway
ExxonMobil, DuPont, and BP are just three of several large corporations investing in advanced biofuels. The sheer magnitudes of the companies and the technological and infrastructural resources available make their investments more likely to pay off in the long run.

Only time will tell whether the future of biofuels will be directed more by already established large corporations or by ambitious younger companies. For investors wanting to get into biofuels without the risk inherent to smaller cap companies, ExxonMobil, DuPont, and BP are all worthy of consideration.

  

Shamus Funk has no position in any stocks mentioned. The Motley Fool owns shares of Solazyme. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Exxon Mobil Corporation Stock Quote
Exxon Mobil Corporation
XOM
$94.38 (2.36%) $2.18
E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
DD
BP p.l.c. Stock Quote
BP p.l.c.
BP
$31.92 (2.01%) $0.63
TerraVia Holdings, Inc. Stock Quote
TerraVia Holdings, Inc.
TVIA
Amyris, Inc. Stock Quote
Amyris, Inc.
AMRS
$3.55 (-3.53%) $0.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
397%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.